- Home
- MIRA vs CUBA Comparison
MIRA vs CUBA Comparison
Compare MIRA & CUBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- CUBA
- Stock Information
- Founded
- MIRA 2020
- CUBA 1992
- Country
- MIRA United States
- CUBA United States
- Employees
- MIRA N/A
- CUBA N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- CUBA Investment Managers
- Sector
- MIRA Health Care
- CUBA Finance
- Exchange
- MIRA Nasdaq
- CUBA Nasdaq
- Market Cap
- MIRA 17.1M
- CUBA 38.4M
- IPO Year
- MIRA 2023
- CUBA N/A
- Fundamental
- Price
- MIRA $2.04
- CUBA $2.42
- Analyst Decision
- MIRA Strong Buy
- CUBA
- Analyst Count
- MIRA 2
- CUBA 0
- Target Price
- MIRA $14.00
- CUBA N/A
- AVG Volume (30 Days)
- MIRA 2.1M
- CUBA 93.9K
- Earning Date
- MIRA 11-11-2024
- CUBA 01-01-0001
- Dividend Yield
- MIRA N/A
- CUBA 20.83%
- EPS Growth
- MIRA N/A
- CUBA N/A
- EPS
- MIRA N/A
- CUBA N/A
- Revenue
- MIRA N/A
- CUBA N/A
- Revenue This Year
- MIRA N/A
- CUBA N/A
- Revenue Next Year
- MIRA N/A
- CUBA N/A
- P/E Ratio
- MIRA N/A
- CUBA N/A
- Revenue Growth
- MIRA N/A
- CUBA N/A
- 52 Week Low
- MIRA $0.51
- CUBA $2.25
- 52 Week High
- MIRA $6.40
- CUBA $4.14
- Technical
- Relative Strength Index (RSI)
- MIRA 79.14
- CUBA 63.96
- Support Level
- MIRA $1.05
- CUBA $2.41
- Resistance Level
- MIRA $1.99
- CUBA $2.46
- Average True Range (ATR)
- MIRA 0.15
- CUBA 0.03
- MACD
- MIRA 0.11
- CUBA 0.00
- Stochastic Oscillator
- MIRA 95.38
- CUBA 75.00
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.